Advertisement

 

 

PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.

PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
Author Information (click to view)

Davidson M, Olsen RJ, Ewton AA, Robbins RJ,


Davidson M, Olsen RJ, Ewton AA, Robbins RJ, (click to view)

Davidson M, Olsen RJ, Ewton AA, Robbins RJ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017 11 16() doi 10.4158/EP-2017-0001

Abstract
OBJECTIVE
Although loco-regional metastases occur in 5-10% of patients with papillary thyroid cancer (PTC), distant metastases are rare, especially to the pancreas. Here we review the literature regarding metastases to the pancreas from PTC and present an illustrative patient.

METHODS
The literature search was performed through www.pubmed.org . The information regarding our illustrative case was obtained from the medical records of our institution.

RESULTS
Since 1991, 11 cases of pancreas metastases of PTC have been reported. The average age at diagnosis was 55.3 years. There were 8 men and 3 women. Three had classic PTC histology; 2 had tall cell variant; and 2 had follicular variant. Four had T4 tumors, and 2 had T3 tumors. Seven had thyroid cancer spread to regional lymph nodes. One had distant metastasis. The pancreas metastasis was diagnosed from 1 month to 13 years after primary PTC was detected; average was 7 years. Our patient was an 84 year old woman diagnosed with PTC with a BRAFV600E mutation following total thyroidectomy. A whole body scan after radioactive iodine (RAI) remnant ablation was negative for metastases. A pancreatic tumor was identified 2 years later, on screening fluoro-deoxyglucose (FDG)-positron emission tomography (PET) scan. A biopsy of the tumor was histologically similar to PTC and positive for thyroglobulin, TTF-1, and the BRAFV600E mutation.

CONCLUSION
The biological reasons why PTCs metastasize to the pancreas have yet to be elucidated. Older patients with non-RAI avid, FDG-PET positive metastases and symptoms of pancreatitis are at increased risk of having this rare entity.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 × two =

[ HIDE/SHOW ]